Paula Ragan - Jun 15, 2021 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
President and CEO, Director
Signature
/s/ Derek M. Meisner, attorney-in-fact
Stock symbol
XFOR
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 05:12 PM
Previous filing
Jun 2, 2021
Next filing
Jun 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Award $0 +44.8K +11.03% $0.00 451K Jun 15, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units issued to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date. One third of the shares underlying the restricted stock unit award vested on June 15, 2021. One third of the shares will vest on June 15, 2022, and one third of the shares will vest on June 15, 2023, subject to the Reporting Person providing continuous service to the Issuer on such dates. Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs.
F2 Of the shares of common stock reported, 262,246 shares represent unvested restricted stock units.